SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
DATE OF REPORT (DATE OF EARLIEST EVENT REPORTED) July 31, 2003
Inverness Medical Innovations, Inc.
(Exact Name of Registrant as Specified in Its Charter)
| Delaware (State or other jurisdiction of incorporation) |
001-16789 (Commission file number) |
04-3565120 (IRS Employer Identification No.) |
||
51 Sawyer Road, Suite 200, Waltham, Massachusetts 02453 (Address of principal executive offices) |
||||
Registrant's telephone number, including area code: (781) 647-3900 |
||||
Not Applicable (Former name or former address, if changed since last report) |
||||
ITEM 7. EXHIBITS
| Exhibit Number |
Description |
|
|---|---|---|
| 99.1 | Press Release dated July 31, 2003, entitled "Inverness Medical Innovations Announces Second Quarter Results" |
ITEM 12. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
On July 31, 2003, Inverness Medical Innovations, Inc. issued a press release entitled "Inverness Medical Innovations Announces Second Quarter Results," a copy of which is furnished with this Current Report on Form 8-K as Exhibit 99.1.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| INVERNESS MEDICAL INNOVATIONS, INC. | |||
By: |
/s/ DUANE L. JAMES Duane L. James Vice President of Finance and Treasurer |
||
| Dated: August 1, 2003 |
|||
3
| Exhibit Number |
Description |
|
|---|---|---|
| 99.1 | Press Release dated July 31, 2003, entitled "Inverness Medical Innovations Announces Second Quarter Results" |
4